MolnuFIP™ EIDD-1931 is the newest antiviral therapy specifically formulated for the treatment of feline infectious peritonitis (FIP). Designed exclusively for veterinary use, MolnuFIP™ eliminates the need for human molnupiravir, offering a targeted, optimized approach for feline patients.
Each MolnuFIP™ capsule is precisely dosed based on a cat’s body weight and metabolic rate, ensuring accurate, consistent treatment with minimal variability.
Proven Efficacy
Clinical researches demonstrate that EIDD-1931 is 4.4 times more potent than human molnupiravir (EIDD-2801) and 7.3 times more potent than GS-441524, enabling faster recovery with fewer side effects.
Comprehensive FIP Coverage
Effective for both wet and dry FIP
Near-zero relapse rate
Optimized for feline metabolism
With MolnuFIP™ EIDD-1931, your cat receives a scientifically advanced, highly effective treatment—bringing them back to full health with precision, safety, and confidence.
Active Ingredient: EIDD-1931
Inactive Ingredient: Dibasic Calcium Phosphate, Magnesium Sterate
Form: Size 3 Capsules
Indications: Ideal for cats with effusive (wet) and non-effusive (dry) FIP symptoms such as fever, ascites, pleural effusion.
Specification: 60 capsules, each containing 15 mg of EIDD-1931
Dosage: 1 capsule every 12 hours per 2.5 kg of body weight, preferably on an empty stomach. If vomiting occurs within 30 minutes, administer another capsule.
Not Recommended For: Ocular or neurological cases, cats not feeding or defecating normally, and cats with a history of poor dietary absorption.
Length of Treatment: Up to 60 days or as recommended by a veterinarian.
Storage: Store in a dry, cool place away from sunlight.
Reviews
Be the first to review
Write an review
How would you rate the product?
More thought about the product